1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood (Q56763544)
scientific article published in 1991
Language:
Current Data About 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood
(P31) (Q13442814)

(P50) (Q47698773)
(P1932) Dominique Schols
(P1545) 3

(Q31332118)
(P1545) 1
(P1932) Jan Balzarini

(P304) 563-569

(P407) (Q1860)

(P433) 2

(P478) 178

(P577) +1991-07-00T00:00:00Z

(P921) (Q421862)
(P887)

(P1433) (Q864228)

(P1476) "1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood" (language: en)

(P2093) Chong-Kyo Lee
(P1545) 2

Erik De Clercq
(P1545) 4

other details
description scientific article published in 1991

External Links
(P356) 10.1016/0006-291X(91)90145-W